Benitec Biopharma (BNTC) Cash Flow: Operating & Free Cash Flow

Benitec Biopharma Cash Flow Statement Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Cash flow statement showing operating, investing, and financing activities for Benitec Biopharma Inc. (BNTC) - Annual data in millions USD
Breakdown	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Jun 2026	Jun 2025	Jun 2024	Jun 2023	Jun 2022	Jun 2021	Jun 2020	Jun 2019	Jun 2018	Jun 2017
Operating Activities
Net Income	-45.55	-37.92	-21.75	-19.56	-18.21	-13.88	-8.27	2.61	-8.55	-4.37
Depreciation & Amortization	0.48	0.40	0.34	0.38	0.39	0.42	0.37	0.16	0.00	0.22
Deferred Income Tax	0.00	0.00	0.00	-0.71	0.00	0.00	0.00	-0.96	0.00	-0.82
Stock Based Compensation	26.41	17.43	0.83	0.45	0.87	0.63	0.24	0.96	0.00	0.39
Change in Working Capital	2.14	-2.73	1.17	0.71	1.04	0.01	0.13	1.32	1.49	0.76
Change in Accounts Receivable	0.03	0.20	-0.18	-0.05	0.00	0.03	2.40	0.61	0.32	0.81
Change in Inventory	0.00	0.00	0.00	-1.31	-1.09	-0.08	-0.70	0.00	0.00	0.00
Change in Accounts Payable	3.27	-2.38	0.94	1.36	1.09	0.06	-1.70	0.74	1.43	0.00
Change in Other Working Capital	-1.17	-0.47	0.37	0.71	-0.13	-0.20	0.13	-0.02	-0.26	-0.05
Other Operating Activities	0.00	-0.76	0.00	0.72	0.01	-0.02	0.00	0.70	-2.73	-4.48
Net Cash from Operating Activities	-16.52	-23.59	-19.40	-18.01	-15.90	-12.83	-7.54	4.79	-8.55	-8.30
Investing Activities
Capital Expenditures	-0.11	-0.02	-0.18	0.00	-0.01	-0.22	-0.10	-0.40	-0.06	-0.13
Acquisitions	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Purchases of Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-0.13
Other Investing Activities	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-0.09	-0.04
Net Cash from Investing Activities	-0.11	-0.02	-0.18	0.00	-0.01	-0.22	-0.09	-0.40	-0.15	-0.30
Financing Activities
Common Stock Issued	104.50	72.80	73.92	17.88	0.00	25.75	2.25	0.00	6.48	6.20
Other Financing Activities	-6.27	-2.32	-5.89	-1.87	0.00	-3.23	-0.48	-0.69	2.03	1.74
Net Cash from Financing Activities	98.98	70.49	68.03	16.02	0.00	22.52	1.77	-0.69	8.51	7.94
Summary
Effect of Forex Changes on Cash	-0.13	0.05	-0.01	0.41	0.20	0.50	-0.06	0.73	0.14	-0.19
Net Change in Cash	82.23	46.93	48.44	-1.59	-15.71	9.97	-5.92	4.43	-1.29	-0.86
Cash at Beginning of Period	97.86	50.93	2.49	4.08	19.78	9.80	15.72	11.26	18.14	17.73
Cash at End of Period	180.09	97.86	50.93	2.49	4.08	19.77	9.80	15.70	16.17	17.44
Free Cash Flow	-16.62	-23.61	-19.58	-18.01	-15.91	-13.05	-7.63	4.39	-8.61	-8.44

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Benitec Biopharma Cash Flow

What is Benitec Biopharma's free cash flow?

Benitec Biopharma had negative free cash flow of $16.62M in fiscal 2026 (fiscal year ended Jun 30, 2026), operating cash flow of −$16.52M minus $105.00K of capital expenditures.

How much does Benitec Biopharma spend on capital expenditures?

Benitec Biopharma spent $105.00K on capital expenditures in fiscal 2026, compared with $18.00K a year earlier.

Does Benitec Biopharma pay dividends or buy back shares?

Benitec Biopharma's cash flow statement for fiscal 2026 shows no dividend payments or share repurchases.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition